Created by Shyam Sunder

AJANTPHARM

AJANTPHARM corporate announcements

Ajanta Pharma Gets Approvals For 3 ANDA's (Company Update)
Author
Fortune India Presents Award To Ajanta Pharma (Company Update)
Author
Ajanta Pharma Receives US FDA Approval For Almotriptan Malate Tablets (Company Update)
Author
Investor Presentation Q4 FY 2016 (Company Update)
Author
Ajanta Pharma Announces The Launch of Montelukast IR Tablets and Montelukast Chewable Tablets (Company Update)
Author
Ajanta Pharma Announces US FDA Approval of Voriconazole Tablets (Company Update)
Author
Authorised KMPs To Determine Materiality of Events/information (Company Update)
Author
Ajanta Pharma Announces The Launch of Montelukast Sodium Oral Granules (Company Update)
Author
Investor Presentation (Company Update)
Author
Ajanta Pharma Announces The Launch of Levetiracetam Tablets (Company Update)
Author
Presentation On Results (Company Update)
Author
Ajanta Pharma Announces The US FDA Approval of Zolmitriptan Tablets (Company Update)
Author
Investor Presentation Q1 FY 2017 (Company Update)
Author
Announces Q1 (Standalone & Consolidated) Results, Limited Review Report (Standalone & Consolidated) & Results Press Release For The Quarter Ended June 30, 2016 (Result)
Author
Ajanta Pharma Announces US FDA Approval For Omeprazole and Sodium Bicarbonate Powder For Oral Suspension (Company Update)
Author
Ajanta Pharma Announces Approval of Aripiprazole Tablets From US FDA (Company Update)
Author
Q2 Results On Oct 26, 2016 (Board Meeting)
Author
Ajanta Pharma Announces Consolidation of Promoter Shareholding (Company Update)
Author
Investor Presentation (Company Update)
Author
Ajanta Pharma Announces Approval & Launch of Amlodipine + Olmesartan Medoxomil Tablets in US Market (Company Update)
Author
Investor Presentation Q3 FY 2017 (Company Update)
Author
Ajanta Pharma Announces US FDA Approval For Duloxetine Hydrochloride Delayed Release Capsules (Company Update)
Author
Clarifies On News Item (Company Update)
Author
No Import Alert On Us by US FDA (Company Update)
Author

AJANTPHARM

Ajanta Pharma Gets Approvals For 3 ANDA's (Company Update)

Fortune India Presents Award To Ajanta Pharma (Company Update)

Ajanta Pharma Receives US FDA Approval For Almotriptan Malate Tablets (Company Update)

Investor Presentation Q4 FY 2016 (Company Update)

Ajanta Pharma Announces The Launch of Montelukast IR Tablets and Montelukast Chewable Tablets (Company Update)

Ajanta Pharma Announces US FDA Approval of Voriconazole Tablets (Company Update)

Authorised KMPs To Determine Materiality of Events/information (Company Update)

Ajanta Pharma Announces The Launch of Montelukast Sodium Oral Granules (Company Update)

Investor Presentation (Company Update)

Ajanta Pharma Announces The Launch of Levetiracetam Tablets (Company Update)

Presentation On Results (Company Update)

Ajanta Pharma Announces The US FDA Approval of Zolmitriptan Tablets (Company Update)

Investor Presentation Q1 FY 2017 (Company Update)

Announces Q1 (Standalone & Consolidated) Results, Limited Review Report (Standalone & Consolidated) & Results Press Release For The Quarter Ended June 30, 2016 (Result)

Ajanta Pharma Announces US FDA Approval For Omeprazole and Sodium Bicarbonate Powder For Oral Suspension (Company Update)

Ajanta Pharma Announces Approval of Aripiprazole Tablets From US FDA (Company Update)

Q2 Results On Oct 26, 2016 (Board Meeting)

Ajanta Pharma Announces Consolidation of Promoter Shareholding (Company Update)

Investor Presentation (Company Update)

Ajanta Pharma Announces Approval & Launch of Amlodipine + Olmesartan Medoxomil Tablets in US Market (Company Update)

Investor Presentation Q3 FY 2017 (Company Update)

Ajanta Pharma Announces US FDA Approval For Duloxetine Hydrochloride Delayed Release Capsules (Company Update)

Clarifies On News Item (Company Update)

No Import Alert On Us by US FDA (Company Update)